Medical specialists from Canada tagged as investigators in clinical trials studying Ocular Hypertension

Total 15 results

Bernard Hurley, MD, FRCSC
Seen in:
- Ontario, Ottawa, The Ottawa Hospital
Trials:
- NCT00744666 (Principal Investigator)
Conditions:
- Ocular Hypertension;
- Vitreoretinal Disease
Carol Schwartz, MD, FRCSC
Seen in:
- Ontario, Toronto, Sunnybrook Health Sciences Centre
Trials:
- NCT00744666 (Sub-Investigator)
Conditions:
- Ocular Hypertension;
- Vitreoretinal Disease
Chirag Shah, MD, FRCSC
Seen in:
- Ontario, Toronto, Toronto Western Hospital
Trials:
- NCT00744666 (Sub-Investigator)
Conditions:
- Ocular Hypertension;
- Vitreoretinal Disease
Christina Leung, MD
Seen in:
- Ontario, Kingston, Hôtel Dieu Hospital
Trials:
- NCT00744666 (Sub-Investigator)
Conditions:
- Ocular Hypertension;
- Vitreoretinal Disease
Daniel Weisbrod, MD, FRCSC
Seen in:
- Ontario, Toronto, Sunnybrook Health Sciences Centre
Trials:
- NCT00744666 (Sub-Investigator)
Conditions:
- Ocular Hypertension;
- Vitreoretinal Disease
David B Yan, M.D., F.R.C.S. (C)
Seen in:
- Ontario, Toronto, Opthalmis Diagnostic Services
Trials:
- NCT02792803 (Principal Investigator)
Conditions:
Delan Jinapriya, MD, FRCSC
Seen in:
- Ontario, Kingston, Hôtel Dieu Hospital
Trials:
- NCT00744666 (Sub-Investigator)
Conditions:
- Ocular Hypertension;
- Vitreoretinal Disease
Jeffery Gale, MD, FRCSC
Seen in:
- Ontario, Kingston, Hôtel Dieu Hospital
Trials:
- NCT00744666 (Principal Investigator)
Conditions:
- Ocular Hypertension;
- Vitreoretinal Disease
Kenneth Eng, MD, FRCSC
Seen in:
- Ontario, Toronto, Sunnybrook Health Sciences Centre
Trials:
- NCT00744666 (Principal Investigator)
Conditions:
- Ocular Hypertension;
- Vitreoretinal Disease
Michael Brent, MD, FRCSC
Seen in:
- Ontario, Toronto, Toronto Western Hospital
Trials:
- NCT00744666 (Principal Investigator)
Conditions:
- Ocular Hypertension;
- Vitreoretinal Disease
Mona Harissi-Dagher, MD
Seen in:
- Quebec, Montréal, Centre Hospitalier de l'Universite de Montreal (CHUM)
Trials:
- NCT04337944 (Principal Investigator)
Conditions:
Patrick Santiago, MD, FRCSC
Seen in:
- Ontario, Toronto, Toronto Western Hospital
Trials:
- NCT00744666 (Sub-Investigator)
Conditions:
- Ocular Hypertension;
- Vitreoretinal Disease
Peter Kertes, MD, FRCSC
Seen in:
- Ontario, Toronto, Sunnybrook Health Sciences Centre
Trials:
- NCT00744666 (Sub-Investigator)
Conditions:
- Ocular Hypertension;
- Vitreoretinal Disease
Sylvia Chen, MD
Seen in:
- Ontario, Ottawa, The Ottawa Hospital
Trials:
- NCT00744666 (Sub-Investigator)
Conditions:
- Ocular Hypertension;
- Vitreoretinal Disease
Toby Chan, MD
Seen in:
- Ontario, Kitchener, Ocular Health Centre
Trials:
- NCT04967989 (Principal Investigator)
Conditions:
- Glaucoma and Ocular Hypertension

Clinical Trials on Ocular Hypertension

Western Galilee Hospital-Nahariya

Unknown

The Effect of Two Different Artificial Respiration Methods on the Intraocular Pressure During Surgery Under General Anesthesia

Intra Ocular Hypertension
Laboratoires Thea

Completed

Efficacy and Safety Assessment of T4030 Eye Drops Versus Ganfort® UD in Ocular Hypertensive or Glaucomatous Patients.

Ocular Hypertension Glaucoma

Bulgaria
Santen Inc.

Completed

A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study

Glaucoma and Ocular Hypertension

United States
University Hospital, Geneva

Terminated

Prospective,Randomized,Controlled Study to Assess Efficacy,Safety, and Tolerability of SLT vs. PLT in Patients With POAG

Glaucoma and Ocular Hypertension

Switzerland
West Virginia University
University of Pittsburgh

Recruiting

Clarifying the Optimal Application of SLT Therapy Trial (COAST)

Glaucoma and Ocular Hypertension

United States, United Kingdom, Canada
Santen Inc.

Completed

A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study

Glaucoma and Ocular Hypertension

United States
Maastricht University Medical Center

Completed

Gene Polymorphisms of Corticosteroid-induced Ocular Hypertension

Corticosteroid Induced Ocular Hypertension/Glaucoma

Netherlands
Santen Inc.

Completed

A Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Patients With POAG or OHT

Glaucoma and Ocular Hypertension

United States
Bausch & Lomb Incorporated

Completed

Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt

Glaucoma | Open Angle or Ocular Hypertension

United States
Nicox Ophthalmics, Inc.

Completed

Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Glaucoma, Open-Angle | Hypertension, Ocular

United States

Medical specialists from Canada tagged as investigators in clinical trials studying Ocular Hypertension

Clinical Trials on Ocular Hypertension

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations